Metrics to compare | 4887 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4887PeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.7x | 15.4x | −0.4x | |
PEG Ratio | −0.60 | 0.18 | 0.00 | |
Price/Book | 1.1x | 1.1x | 2.6x | |
Price / LTM Sales | 0.9x | 1.6x | 3.1x | |
Upside (Analyst Target) | 31.6% | 16.2% | 49.3% | |
Fair Value Upside | Unlock | 10.3% | 6.7% | Unlock |
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals. The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others. It sells its generic drugs through distributors, wholesalers, and retailers. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.